Cargando…
血细胞积分对以硼替佐米为基础一线治疗的多发性骨髓瘤患者的预后评估作用
OBJECTIVE: This study aims to evaluate the prognostic effect of peripheral blood cells in multiple myeloma(MM)patients treated with bortezomib. METHODS: The clinical data of 155 newly diagnosed MM patients in two blood disease treatment centers from January 2014 to December 2016 were retrospectively...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595856/ https://www.ncbi.nlm.nih.gov/pubmed/33113608 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2020.09.009 |
Ejemplares similares
-
CD56和(或)CD117表达在以硼替佐米为基础一线治疗的初诊多发性骨髓瘤患者中的预后意义
Publicado: (2019) -
硼替佐米家庭治疗的探索
Publicado: (2020) -
硼替佐米、糖皮质激素为基础的联合方案治疗6例复发/难治免疫性血栓性血小板减少性紫癜
Publicado: (2023) -
中药“神经方”对硼替佐米所致周围神经病变治疗作用的实验研究
Publicado: (2015) -
硼替佐米为基础的化疗序贯自体造血干细胞移植治疗伴1q21扩增初治多发性骨髓瘤患者疗效分析
Publicado: (2018)